TRULIEVE CANNABIS CORP
TRLVNYSETrading Snapshot
- Day Range
- $10.36 – $10.85
- 52-Week Range
- $4.62 – $13.28
- Volume (shares)
- 1,030,398
- Avg Volume (shares)
- —
- Shares Outstanding
- 170.2M
- Next Earnings
- 2026-11-05
Fundamentals Snapshot
- Annual Revenue
- $1.18B
- Last Q Revenue
- $271M
- P/E Ratio
- -4.3
- P/S Ratio
- 1.6x
- EPS (TTM)
- $-2.46
- Dividend Yield
- 0.00%
TRULIEVE CANNABIS CORP
TRLVFinancial history unavailable.
StockOtter · stockotter.spaceAbout TRULIEVE CANNABIS CORP
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Analyst Ratings
ⓘLatest News & Updates
Trulieve Cannabis Corp (TRLV) Shares Fall 4.6% -- GF Value Says Still Overvalued
On October 23, 2026, Trulieve Cannabis Corp (TRLV) shares fell 4.6%, currently priced at $10.42. This move comes amid a 52-week range of $4.62 to $13.28, indica
Head to Head Analysis: Sol-Gel Technologies (NASDAQ:SLGL) vs. Trulieve Cannabis (NYSE:TRLV)
Trulieve Cannabis (NYSE: TRLV - Get Free Report) and Sol-Gel Technologies (NASDAQ: SLGL - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based
3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds
Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.
Trulieve Repays $65 Million Mortgage Strengthening Balance Sheet
TALLAHASSEE, Fla., Oct. 7, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the full repayment of
Trulieve Cannabis Corp. to Hold Third Quarter 2026 Results Conference Call on November 5, 2026
TALLAHASSEE, Fla., Oct. 6, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV ) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., will hold a conference call on Thurs
2 High-Octane Cannabis Stocks to Buy in October for Aggressive Investors
The two pot companies had higher second-quarter profit. Their balance sheets are stronger than other companies in the sector.